Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Solid Biosciences (SLDB) Accumulated Depreciation & Amortization (2017 - 2024)

Solid Biosciences' Accumulated Depreciation & Amortization history spans 7 years, with the latest figure at $13.1 million for Q1 2024.

  • For Q1 2024, Accumulated Depreciation & Amortization rose 20.22% year-over-year to $13.1 million; the TTM value through Mar 2024 reached $13.1 million, up 20.22%, while the annual FY2023 figure was $12.7 million, 16.24% up from the prior year.
  • Accumulated Depreciation & Amortization for Q1 2024 was $13.1 million at Solid Biosciences, up from $12.7 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $13.1 million in Q1 2024 and bottomed at $5.8 million in Q1 2020.
  • The 5-year median for Accumulated Depreciation & Amortization is $10.9 million (2021), against an average of $10.5 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization surged 98.67% in 2020 before it decreased 13.61% in 2022.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $8.7 million in 2020, then surged by 33.83% to $11.7 million in 2021, then decreased by 6.05% to $11.0 million in 2022, then grew by 16.24% to $12.7 million in 2023, then grew by 2.49% to $13.1 million in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Accumulated Depreciation & Amortization are $13.1 million (Q1 2024), $12.7 million (Q4 2023), and $12.1 million (Q3 2023).